CLCN7 Antibody Summary
| Immunogen |
A synthetic peptide from the cytoplasmic domain of human Chloride channel protein 7 (CLCN7) conjugated to an immunogenic carrier protein was used as the immunogen. |
| Specificity |
Appears to be specific for CLCN7. |
| Isotype |
IgG |
| Clonality |
Polyclonal |
| Host |
Rabbit |
| Gene |
CLCN7 |
| Purity |
Unpurified |
| Innovator's Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase. |
Applications/Dilutions
| Dilutions |
- Immunohistochemistry 1:10-1:500
- Immunohistochemistry-Frozen 1:300 - 1:2000
- Immunohistochemistry-Paraffin 1:300 - 1:2000
- Western Blot 1:300-1:2000
|
Reactivity Notes
Other species not yet tested.
Packaging, Storage & Formulations
| Storage |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer |
Whole antisera |
| Preservative |
No Preservative |
| Concentration |
LYOPH |
| Purity |
Unpurified |
| Reconstitution Instructions |
Reconstitute with 0.1 ml sterilized water to desired concentration. |
Alternate Names for CLCN7 Antibody
Background
The product of this gene belongs to the CLC chloride channel family of proteins. Chloride channels play important roles in the plasma membrane and in intracellular organelles. This gene encodes chloride channel 7. Defects in this gene are the cause of osteopetrosis autosomal recessive type 4 (OPTB4), also called infantile malignant osteopetrosis type 2 as well as the cause of autosomal dominant osteopetrosis type 2 (OPTA2), also called autosomal dominant Albers-Schonberg disease or marble disease autosoml dominant. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. OPTA2 is the most common form of osteopetrosis, occurring in adolescence or adulthood.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are
guaranteed for 1 year from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: IHC, IHC-P, WB
Species: Hu, Mu, Rt
Applications: ELISA, ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: ELISA, ICC/IF, WB
Species: Hu, Mu, Rt
Applications: IHC, IHC-P, WB
Species: Mu, Rt
Applications: WB
Species: Hu
Applications: CyTOF-ready, ICFlow, WB
Species: Hu
Applications: IHC, WB
Species: Mu
Applications: BA
Species: Hu, Mu, Rt
Applications: IHC, IHC-P, WB
Species: Hu
Applications: ELISA, KD, S-ELISA, WB
Species: Hu
Applications: IHC, IHC-P
Species: Hu
Applications: ELISA, ICC/IF, IHC, IHC-P, WB
Species: Av, Hu, Mu, Rt
Applications: CyTOF-ready, Flow-IC, Flow, IHC, IHC-P, WB
Species: Hu
Applications: IHC, IP, WB
Species: Hu, Mu
Applications: ELISA, IHC, IHC-Fr, IHC-P, Simple Western, WB
Species: Hu
Applications: WB
Species: Hu, Mu, Rt
Applications: ELISA, WB
Species: Hu, Mu, Rt
Applications: ELISA, IHC, IP, WB
Publications for CLCN7 Antibody (NBP1-30854) (0)
There are no publications for CLCN7 Antibody (NBP1-30854).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for CLCN7 Antibody (NBP1-30854) (0)
There are no reviews for CLCN7 Antibody (NBP1-30854).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Video Protocols
FAQs for CLCN7 Antibody (NBP1-30854). (Showing 1 - 1 of 1 FAQ).
-
Could you please tell me the exact epitope for this antibody?
- We do not perform epitope mapping of our antibodies, so unfortunately, I do not have the epitope recognized by NBP1-30854.
Secondary Antibodies
| |
Isotype Controls
|
Additional CLCN7 Products
Research Areas for CLCN7 Antibody (NBP1-30854)
Find related products by research area.
|
Blogs on CLCN7